Aspirin for primary prevention of cardiovaascular events: what are the evidances?
Cardiovascular disease (CVD) is the leading cause of mortality in the United States, accounting for about 1 in 3 deaths.(1) In view of the healthcare and economic burdens of cardiovascular disease, the public health aim should be the prevention of cardiovascular events through risk factor optimizati...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Faculty of Medicine Trisakti University
2019-08-01
|
| Series: | Universa Medicina |
| Online Access: | https://univmed.org/ejurnal/index.php/medicina/article/view/875 |